Direct oral anticoagulants (DOACs) are a common treatment for patients with a wide variety of cardiovascular conditions.
Psilera Welcomes Biopharma Executive Dr. Magali Haas to its Board of Directors | Psychedelic Invest
TAMPA – Psilera, a leading biotechnology company developing groundbreaking therapies for hard-to-treat neurological disorders, is pleased to announce the appointment of Magali Haas, M.D., Ph.D., to its